ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
PAVmed Inc

PAVmed Inc (PAVM)

1.02
-0.01
( -0.97% )
Actualizado: 14:08:00

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
1.02
Postura de Compra
1.01
Postura de Venta
1.02
Volume Operado de la Acción
40,038
1.01 Rango del Día 1.085
0.5999 Rango de 52 semanas 4.875
Capitalización de Mercado [m]
Precio Anterior
1.03
Precio de Apertura
1.03
Última hora de negociación
14:07:59
Volumen financiero
US$ 41,753
Precio Promedio Ponderado
1.0428
Volumen promedio (3 m)
65,291
Acciones en circulación
11,068,566
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.17
Beneficio por acción (BPA)
-5.99
turnover
2.45M
Beneficio neto
-66.27M

Acerca de PAVmed Inc

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
PAVmed Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker PAVM. The last closing price for PAVmed was US$1.03. Over the last year, PAVmed shares have traded in a share price range of US$ 0.5999 to US$ 4.875.

PAVmed currently has 11,068,566 shares in issue. The market capitalisation of PAVmed is US$11.40 million. PAVmed has a price to earnings ratio (PE ratio) of -0.17.

PAVM Últimas noticias

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test PR Newswire NEW YORK, Nov. 20, 2024 NEW YORK, Nov. 20, 2024 /PRNewswire/...

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

PAVmed Provides Business Update and Third Quarter 2024 Financial Results

PAVmed Provides Business Update and Third Quarter 2024 Financial Results PR Newswire NEW YORK, Nov. 14, 2024 Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence...

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Nov. 7...

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers PR Newswire NEW YORK, Nov. 5, 2024 Industry veterans from leading cancer...

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 PR Newswire NEW YORK, Oct. 31, 2024 Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, Oct. 31, 2024...

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024 PR Newswire NEW YORK, Oct. 30, 2024 Conference Call and Webcast at 8:30AM Eastern Time NEW YORK, Oct...

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test PR Newswire NEW YORK, Oct. 15, 2024 Patent covers proprietary method using methylation of...

PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care

PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care PR Newswire NEW YORK, Oct. 10, 2024 Grant will fund research to optimize Veris Cancer Care Platform for...

Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit

Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit PR Newswire NEW YORK, Oct. 9, 2024 NEW YORK, Oct. 9, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq:...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1001.021.170.991140411.07252371CS
4-0.03-2.857142857141.051.210.99530431.07305179CS
120.1213.33333333330.91.90.8652911.27124788CS
26-0.78-43.33333333331.81.960.5999650031.12095707CS
52-2.145-67.77251184833.1654.8750.59991013762.61428569CS
156-63.18-98.411214953364.264.4250.599968362118.95215192CS
260-13.53-92.989690721614.55145.50.5999116453047.52156657CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CRNCCerence Inc
US$ 6.099
(116.28%)
71.27M
WORXSCWorx Corporation
US$ 2.05
(109.18%)
131.71M
ARQQArqit Quantum Inc
US$ 10.7901
(47.00%)
743.81k
SPAISafe Pro Group Inc
US$ 4.61
(44.06%)
39.82M
PROCProcaps Group SA
US$ 0.771
(34.91%)
1.2M
SKKSKK Holdings Limited
US$ 0.8365
(-81.66%)
28M
TMTCTMT Acquisition Corporation
US$ 2.43
(-62.27%)
360.04k
WCTWellchange Holdings Company Limited
US$ 1.2657
(-61.88%)
1.95M
TMTCUTMT Acquisition Corporation
US$ 2.99
(-55.24%)
11.76k
GLXGGalaxy Payroll Group Ltd
US$ 1.81
(-53.71%)
2.23M
CDTConduit Pharmaceuticals Inc
US$ 0.1078
(16.79%)
554.41M
NVDANVIDIA Corporation
US$ 147.62
(1.19%)
324.48M
ELABElevai Labs Inc
US$ 0.0202
(-5.61%)
220.57M
AKTSAkoustis Technologies Inc
US$ 0.102
(17.11%)
200.32M
MARAMARA Holdings Inc
US$ 24.374
(7.71%)
139.59M

PAVM Discussion

Ver más
Monksdream Monksdream 5 meses hace
PAVM under $2
👍️0
Monksdream Monksdream 10 meses hace
PAVM new 52 week low
👍️0
Monksdream Monksdream 11 meses hace
PAVM new 52 week low
👍️0
Mattrixinvest Mattrixinvest 1 año hace
Boom
👍️0
Monksdream Monksdream 1 año hace
PAVM new 52 week low
👍️0
Porterhouse10 Porterhouse10 3 años hace
Boom! Haaa
👍️0
Thunderstruck Thunderstruck 3 años hace
PAVM....Why the drop?? wasn't there just good news out in regards to this company and Lucid??
👍️0
Prfmf1 Prfmf1 3 años hace
Looks like they are trying to keep the stock around or under $7.50 to burn the August 20 options holders.
👍️0
TrendTrade2016 TrendTrade2016 3 años hace
not bullish...but bouncing. No microcaps are bullish right now...play with caution!!!
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 3 años hace
$PAVM Chart looking bullish here..
https://twitter.com/QuabbinR/status/1419357207557193733?s=20
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 años hace
Was the CEO really arrested last week for fraud? Would it be the first time? Need to do a little more looking at it....right?
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 años hace
Looking good like a stinky pile of crap. PAVM is going nowhere! lolzzzzzzzz
👍️0
bUrRpPPP! bUrRpPPP! 3 años hace
Looking good!
👍️0
Prfmf1 Prfmf1 3 años hace
What are your expectations going forward?
👍️0
TrendTrade2016 TrendTrade2016 3 años hace
PAVM there's a monster breaking out of its chains!!
👍️0
Prfmf1 Prfmf1 3 años hace
Short time PAVM holder and looking for big things to happen with this stock. My average buying price is in the low 4's.
👍️0
Flycanuck Flycanuck 3 años hace
Thanks for the tip. Will have a look .
👍️0
Flycanuck Flycanuck 3 años hace
Got Z warrants and shares too. Have not sold yet. Holding through this run up.
👍️0
rumrunner528 rumrunner528 3 años hace
Thank you, ConstitutionNow.

rum
👍️0
ConstitutionNow ConstitutionNow 3 años hace
Visit stocktwits.com at all? Lots of long term holders on there that have a good pulse on what's happening. I know Lucid spinoff is in the works, 3 clinics in phoenix about to open for eso testing. Eso 'in stock' at like 180 clinics around US. Do some quick numbers on a each test and you can see revs could scale quickly. Throw in nexflo, carpx etc and pavmed could be a great long term investment.
👍️0
rumrunner528 rumrunner528 3 años hace
Good for you, ConstitutionNow. I have z's and shares and have been lightening my position as it's run up. I wish I knew what's going on other than the recent PRs.

rum
👍️0
ConstitutionNow ConstitutionNow 4 años hace
Need a message at the top other than Clay...bad luck anytime he posts. Still sittin on a pile of z warrants...very bright future here! Eso, carpx etc...
👍️0
ClayTrader ClayTrader 4 años hace
* * $PAVM Video Chart 04-06-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Bertsllc Bertsllc 4 años hace
Cantor Fitzgerald analysis upgraded PAVM to overweight with the new target of $8.00.

https://www.benzinga.com/news/21/03/20397441/cantor-fitzgerald-initiates-coverage-on-pavmed-with-overweight-rating-announces-price-target-of-8

👍️0
ConstitutionNow ConstitutionNow 4 años hace
Little late in response here, but good analysis of the latest money raise. Solid move by management to get debt off books, lower dilution and cash leftover to fund commercialization. I think the market is starting to realize it now and we should move north on much more solid ground...where they can raise more cash at prices which don't hurt so much.
👍️0
Flycanuck Flycanuck 4 años hace
from the March 2020 S-3A (link below - page 5), I counted about 14 million shares could have been issued by the convertibles. So actually longer term they have about 4 million shares LESS outstanding plus all the cash you mentioned above. Win / Win.
https://www.sec.gov/Archives/edgar/data/1624326/000149315220005215/forms-3a.htm
👍️0
Flycanuck Flycanuck 4 años hace
"PAVmed intends to use the net proceeds from the offering to repay all of the company’s outstanding debt, including all outstanding convertible notes, with the balance to be used for working capital and general corporate purposes."

People don't realize, this doesn't increase dilution. It's a near wash in shares added, becasue the outstanding convertible shares are taken off the books by paying off the convertible holders. It increases float, but not outstanding.

Then the proceeds pay off all other debt, and the company still has around 30M from the offering to use for operations. It's a huge win for the company and shareholders.
👍️0
ClayTrader ClayTrader 4 años hace
* * $PAVM Video Chart 02-22-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
tone3 tone3 4 años hace
Must read article on Seeking Alpha. Target prices from a low of 5.50 up to 12 bucks
👍️0
ConstitutionNow ConstitutionNow 4 años hace
No odea what you are talking about...posted on twitter???????????
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 años hace
When will the new Offering/Dilution for 2021 be announced?

Saw it posted on twitter
👍️0
rumrunner528 rumrunner528 4 años hace
Thank you.
👍️0
ConstitutionNow ConstitutionNow 4 años hace
I've dug into those a bit, from what I can tell they are exercisable at a $1.60 a common share. Expire 2024. Slightly more risky than common but not much, if only one of their products take off, imo the warrants are much better investment dollar for dollar.
👍️0
rumrunner528 rumrunner528 4 años hace
👍️0
rumrunner528 rumrunner528 4 años hace
Does anyone know the terms of the PAVMZ warrants? The 10K is very confusing (or perhaps I'm just not that bright).
👍️0
jaj-dan jaj-dan 4 años hace
Gaining lots of credibility here.
👍️0
jaj-dan jaj-dan 4 años hace
PAVmed to join key indexes this month, shares +5% https://seekingalpha.com/news/3583795-pavmed-to-join-key-indexes-this-month-sharesplus-5
👍️0
jaj-dan jaj-dan 4 años hace
News from yesterday. Probably why the price is moving up.

Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor https://seekingalpha.com
👍️0
jaj-dan jaj-dan 4 años hace
I was just repeating the talking points from the conference call.
👍️0
Bickema Bickema 4 años hace
"PAVmed had cash and cash equivalents of $8.7 million as of March 31, 2020, compared with $6.2 million as of December 31, 2019. Subsequently, in late April 2020, the Company received approximately $3.6 million in proceeds from a private placement with an institutional investor for the sale of a Senior Secured Convertible Note."

Looks like they $12 million in cash no?
👍️0
Cubzgrl Cubzgrl 4 años hace
Moving north!!!! Lets get back to the $6.00s lol
👍️0
jaj-dan jaj-dan 4 años hace
https://ir.pavmed.com/news-events/press-releases/detail/121/pavmed-collaborates-with-canon-on-disappear-pediatric
👍️0
jaj-dan jaj-dan 4 años hace
PAVMed Is About To Enter The Commercialization Phase https://seekingalpha.com/article/4350867-pavmed-is-to-enter-commercialization-phase
👍️0
tjguy tjguy 4 años hace
Is the European approval of CarpX coming up soon?
👍️0
jaj-dan jaj-dan 5 años hace
I don’t really care if it dips here. There’s plenty of firms targeting this at $9-$10. It’s one of my best positions at the moment. I’m holding.
👍️0
jaj-dan jaj-dan 5 años hace
They didn’t really have much to say on the call. They were impacted by the virus with elective surgeries being postponed. They also commented that esoguard could be spun off into another company to raise money
👍️0
jaj-dan jaj-dan 5 años hace
There was only 1 analyst on the call. That’s not good. Management sounded very competent answering questions
👍️0
elcheepo elcheepo 5 años hace
thats a lot of cash they burned... they need to slow down
👍️0
jaj-dan jaj-dan 5 años hace
They said that their CarpX device will make 80-85% return
👍️0
jaj-dan jaj-dan 5 años hace
Re: PAVM
Some people may have bought hoping for a partnership deal announced. These things take time. You won't get a great deal if you are in a hurry.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock